Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer | Zendy

Zhenwen Zhao | Zendy; Yijin Xiao | Zendy; Paul Elson | Zendy; Haiyan Tan | Zendy; Sarah J. Plummer | Zendy; Michael Berk | Zendy; Phyu P. Aung | Zendy; Ian C. Lavery | Zendy; Jean Paul Achkar | Zendy; Li Li | Zendy; Graham Casey | Zendy; Yan Xu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer

Author(s) -

Zhenwen Zhao,

Yijin Xiao,

Paul Elson,

Haiyan Tan,

Sarah J. Plummer,

Michael Berk,

Phyu P. Aung,

Ian C. Lavery,

Jean Paul Achkar,

Li Li,

Graham Casey,

Yan Xu

Publication year - 2007

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2006.08.5571

Subject(s) - medicine , lysophosphatidylcholine , colorectal cancer , receiver operating characteristic , confidence interval , logistic regression , gastroenterology , cancer , oncology , biology , phospholipid , genetics , membrane , phosphatidylcholine

Plasma levels of lysophospholipids were evaluated as potential biomarkers for colorectal cancer (CRC), where a highly reliable and minimally invasive blood test is lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research